Patrick Hall Lizotte, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Screening Assays, Antitumor | 1 | 2018 | 720 | 0.510 |
Why?
|
Immunophenotyping | 3 | 2017 | 1865 | 0.500 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2018 | 1801 | 0.450 |
Why?
|
Thoracic Neoplasms | 1 | 2016 | 267 | 0.450 |
Why?
|
Mesothelioma | 2 | 2016 | 771 | 0.430 |
Why?
|
Tumor Microenvironment | 7 | 2024 | 3948 | 0.420 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 938 | 0.410 |
Why?
|
Head and Neck Neoplasms | 6 | 2024 | 2918 | 0.390 |
Why?
|
Immune Tolerance | 2 | 2016 | 2324 | 0.340 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13448 | 0.300 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 450 | 0.280 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2022 | 5388 | 0.280 |
Why?
|
Flow Cytometry | 2 | 2017 | 5879 | 0.270 |
Why?
|
Immunotherapy | 8 | 2024 | 4752 | 0.260 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2024 | 4038 | 0.250 |
Why?
|
Cell Line, Tumor | 16 | 2024 | 17062 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5693 | 0.220 |
Why?
|
Killer Cells, Natural | 3 | 2022 | 2207 | 0.220 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2024 | 5336 | 0.220 |
Why?
|
T-Lymphocytes | 3 | 2018 | 10262 | 0.210 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2022 | 1761 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2023 | 4642 | 0.200 |
Why?
|
Cell Dedifferentiation | 1 | 2022 | 125 | 0.190 |
Why?
|
Toxoplasma | 2 | 2013 | 158 | 0.190 |
Why?
|
Spheroids, Cellular | 2 | 2021 | 328 | 0.190 |
Why?
|
Ikaros Transcription Factor | 1 | 2021 | 230 | 0.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2896 | 0.160 |
Why?
|
Luciferases, Firefly | 1 | 2018 | 36 | 0.160 |
Why?
|
Mouth Neoplasms | 1 | 2024 | 594 | 0.150 |
Why?
|
Neoadjuvant Therapy | 4 | 2024 | 2895 | 0.150 |
Why?
|
Precancerous Conditions | 1 | 2024 | 974 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1364 | 0.130 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1229 | 0.120 |
Why?
|
Mice | 19 | 2024 | 81792 | 0.120 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 562 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 352 | 0.120 |
Why?
|
Coculture Techniques | 1 | 2018 | 1336 | 0.120 |
Why?
|
Hydroxamic Acids | 1 | 2017 | 483 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11865 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 561 | 0.110 |
Why?
|
Organoids | 1 | 2020 | 739 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2570 | 0.110 |
Why?
|
Genes, Tumor Suppressor | 1 | 2018 | 1059 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8603 | 0.100 |
Why?
|
Dendritic Cells | 1 | 2024 | 2746 | 0.100 |
Why?
|
Animals | 20 | 2024 | 168731 | 0.100 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2013 | 386 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1511 | 0.100 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 778 | 0.100 |
Why?
|
Models, Immunological | 1 | 2014 | 517 | 0.100 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 581 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1129 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2021 | 1661 | 0.090 |
Why?
|
Transcription Factors | 2 | 2021 | 12123 | 0.090 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1036 | 0.080 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5824 | 0.080 |
Why?
|
Mutation | 7 | 2022 | 30184 | 0.080 |
Why?
|
Lung | 2 | 2020 | 10031 | 0.080 |
Why?
|
Immunohistochemistry | 3 | 2020 | 11007 | 0.080 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9548 | 0.080 |
Why?
|
Melanoma, Experimental | 1 | 2012 | 556 | 0.080 |
Why?
|
Gene Dosage | 1 | 2013 | 1213 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2538 | 0.080 |
Why?
|
Mice, Inbred C57BL | 5 | 2018 | 22321 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3593 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2022 | 7849 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4269 | 0.080 |
Why?
|
Hematopoiesis | 1 | 2018 | 2061 | 0.080 |
Why?
|
Cancer Vaccines | 2 | 2013 | 1044 | 0.080 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 1105 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2020 | 10428 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 3110 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2941 | 0.070 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 995 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18289 | 0.070 |
Why?
|
Humans | 30 | 2024 | 765734 | 0.070 |
Why?
|
Glioblastoma | 1 | 2022 | 3459 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9368 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5501 | 0.070 |
Why?
|
Apoptosis | 2 | 2020 | 9511 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3605 | 0.060 |
Why?
|
Cell Lineage | 1 | 2014 | 2573 | 0.060 |
Why?
|
Ovarian Neoplasms | 2 | 2013 | 4900 | 0.060 |
Why?
|
Pyrimidines | 1 | 2017 | 3044 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9594 | 0.060 |
Why?
|
Chemokine CCL5 | 1 | 2024 | 214 | 0.050 |
Why?
|
Leukoplakia, Oral | 1 | 2024 | 79 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13639 | 0.050 |
Why?
|
Nanoparticles | 1 | 2014 | 1962 | 0.050 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 160 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2018 | 1740 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2022 | 9071 | 0.040 |
Why?
|
Tumor Escape | 2 | 2013 | 371 | 0.040 |
Why?
|
Melanoma | 1 | 2018 | 5690 | 0.040 |
Why?
|
Interferons | 1 | 2023 | 714 | 0.040 |
Why?
|
Genes, ras | 1 | 2022 | 657 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2021 | 737 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2022 | 14445 | 0.040 |
Why?
|
Female | 13 | 2024 | 395961 | 0.040 |
Why?
|
Male | 12 | 2024 | 363585 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2022 | 561 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2013 | 3169 | 0.040 |
Why?
|
Neoplasms | 3 | 2017 | 22345 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1172 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 72 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 330 | 0.040 |
Why?
|
Gene Amplification | 1 | 2022 | 1089 | 0.040 |
Why?
|
Thymus Gland | 1 | 2022 | 1260 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2021 | 1752 | 0.030 |
Why?
|
Survival Analysis | 2 | 2021 | 10069 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4262 | 0.030 |
Why?
|
Molecular Structure | 1 | 2021 | 1885 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 195 | 0.030 |
Why?
|
Angiomyolipoma | 1 | 2018 | 188 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1002 | 0.030 |
Why?
|
Cell Survival | 2 | 2020 | 5747 | 0.030 |
Why?
|
Frameshift Mutation | 1 | 2018 | 392 | 0.030 |
Why?
|
Apyrase | 1 | 2018 | 373 | 0.030 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 206 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 741 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3273 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2021 | 1272 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1880 | 0.030 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2018 | 325 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59459 | 0.030 |
Why?
|
Genetic Engineering | 1 | 2020 | 933 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3419 | 0.030 |
Why?
|
Protozoan Vaccines | 1 | 2013 | 13 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1749 | 0.030 |
Why?
|
Injections, Intradermal | 1 | 2012 | 116 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2017 | 714 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2666 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1892 | 0.020 |
Why?
|
Base Sequence | 2 | 2013 | 12402 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2012 | 312 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 788 | 0.020 |
Why?
|
Middle Aged | 6 | 2024 | 222903 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6832 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5381 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2013 | 385 | 0.020 |
Why?
|
Alcohol Oxidoreductases | 1 | 2011 | 164 | 0.020 |
Why?
|
Paired Box Transcription Factors | 1 | 2011 | 204 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4331 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2013 | 827 | 0.020 |
Why?
|
Cytokines | 2 | 2017 | 7424 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1651 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6109 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6219 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2013 | 962 | 0.020 |
Why?
|
Aged | 5 | 2021 | 171050 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4106 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2011 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2011 | 745 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3431 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1837 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8528 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4020 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6307 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2627 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7584 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1884 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15542 | 0.020 |
Why?
|
Spleen | 1 | 2013 | 2295 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4885 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6754 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7599 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2018 | 2175 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3651 | 0.020 |
Why?
|
Oncogenes | 1 | 2011 | 1232 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1998 | 0.020 |
Why?
|
Adult | 4 | 2021 | 222974 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4862 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 13024 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 65180 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2013 | 3504 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17595 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4779 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5924 | 0.010 |
Why?
|
Macrophages | 1 | 2013 | 5772 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41631 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29899 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23589 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 54795 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 12800 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59852 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18061 | 0.010 |
Why?
|